Healthcare 3D Printing Market Size By Product (Syringe based, Magnetic Levitation, Laser Based, Inkjet Based), By Technology (Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), Stereolithography), By Application (Biosensors, Medical {Pharmaceuticals, Prosthetics and Implants, Tissue and Organ Generation}, Dental), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

Published Date: Jun 2021  |  Report ID: GMI1997  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 120   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Healthcare 3D Printing Market size was valued at over USD 1.7 billion in 2020 and is estimated to expand with a CAGR of more than 22.3% between 2021 and 2027. Healthcare 3D printing involves various 3D printing products and services employed in the healthcare sector. While 3D printing gains prominence in the overall manufacturing sector, it has also witnessed significant adoption within the healthcare sector and novel application areas have emerged for the same. One of the prominent factors contributing to this is the rising demand for patient-specific implants in orthopaedic, dental and other types of surgeries. Further, enhanced productivity, coupled with increased production accuracy are other factors leading the market growth.
 

Healthcare 3D Printing Market Overview

Get more details on this report - Request Free Sample PDF
 

3D printing offers numerous technological advancements over the conventional manufacturing process, widening its scope of applications across sectors. Healthcare 3D printing devices are noted to be used in tissue engineering, bioprinting as well as burn related surgeries. Such technology has enabled 3D printing to create layers of human skin sustaining the lives of individuals that have met with critical accidents and suffered through major injuries. Several hospitals are observed to have adopted such devices leading to increasing demand for such technologically advanced devices, hence optimistically affecting the market. Several industry players have focused their efforts on R&D activities to introduce certain innovations in healthcare 3D printing enabling scanning via smartphone devices. Ease and convenience provided by such technology is noted to hold significant potential to largely improve human health, thereby propelling the industry growth.
 

The increasing cases of COVID-19 across the globe have compelled the authorities to restrict the movement of people and goods across regions. This has considerably impacted the growth of each sector and every industry operating within. Large-scale organizations to small enterprises have showcased a shrink in sales. While some areas of the healthcare sector remain to be impacted, the demand for healthcare 3D printing has increased. With the onset of COVID-19 pandemic, several countries reported a shortage of ventilators, among other equipment.
 

3D printing is increasingly used to develop several parts of ventilators, augmenting its healthcare 3D printing market expansion in 2020. Further, several studies are underway to understand the level of impact that coronavirus has on major organs of the body. Hence, it can increasingly be employed in organ generation, further fuelling the market. It is also anticipated that as healthcare institutions open up for non-essential surgeries and implants, safety protocols can be implemented surrounding the production method of implants, which can optimistically impact the market, both in the short-term and long-term forecast period.
 

Successful implementation of 3D printing in various applications leads to faster commercialization of the technology

The applications for healthcare 3D printing have grown significantly. 3D printing is largely employed to produce bones, jawbone, hearing aid, cell cultures, exoskeletons, windpipes, eyeglasses, tissues, stem cells, blood vessels, vascular networks, organs, as well as new dosage forms and drug delivery devices. Several biotech companies are focusing on creating tissues and organs for medical research. Some research centres are observed to involve researchers in creating artificial organs to study the effects of drugs on the functioning of those organs. An increasing popularity of the animal rights movement is expected to impel the application of 3D printing in pre-human clinical trial phases.
 

3D printing serves as superior platform to develop novel drugs. Additionally, stem cells are observed to be bio printed in institutional laboratories. Stem cell printing is one of the pioneering fields to print different kinds of tissues leading to print cells and tissues directly into parts of the body. Significant advancements are observed in disease cells and cancer cells that can be bio printed, for the effective study of the growth of tumours. Such advancements in medical engineering allows better drug testing thus boosting the industry expansion in developed countries of Europe and North America.
 

Shortage of skilled labour is poised to hamper the healthcare 3D printing market progression

The implementation of healthcare 3D printing represents a paradigm shift in designing and production technologies. Hence, well-trained engineers and technicians are very crucial to expand the usage of such technology. Many of the innovative technologies have outpaced the ability of the broader manufacturing workforce to adapt and several manufacturers have started the struggle associated with finding skilled workers. There is a significant impact on innovation, growth production and quality. However, the rising demand for skilled labour is not met. Thus, the shortage in talent faced by industry is widely recognized.
 

Syringe based segment is predicted to dominate throughout the forecast period

Healthcare 3D Printing Market Size

Get more details on this report - Request Free Sample PDF

 

Syringe based segment captured more than 40% of the market share in 2020. One of the leading factors influencing its market demand is the extensive use of 3D printers in the field of bioprinting, food printing and embedded printing. As implementation of the technology is still in its infancy, the demand is set to increase in the coming years as the wider audience in the healthcare industry adopts 3D printing.
 

Rising surgical volumes involving surgical implants considerably accelerate the segment growth

The fuel deposition modelling segment in the healthcare 3D printing market is slated to reach USD 3 billion by 2027. Implants used during surgeries are largely manufactured using FDM technology. Among several factors, the increasing number of road accidents is significantly stimulating the demand for healthcare 3D printing, particularly through FDM technology. Precise and custom implants can be developed specifically considering the patient’s anatomy.
 

Medical segment is expected to remain highly driven through the forecast period

The medical segment will witness a 22.5% growth rate through 2027. Medical application includes the development of surgical implants as well as tissue scaffold printing and cell printing. These are some of the foremost technological advantages of healthcare 3D printing, thereby enhancing the industry progression.
 

Early- acceptance and supportive stance of authorities propel the demand in the North America region

Global Healthcare 3D Printing Market

Get more details on this report - Request Free Sample PDF

 

North America healthcare 3D printing market size was over USD 701.4 million in 2020. The increasing regulatory support to enhance quality control measures as well as streamlining the integration of 3D printing and conventional technologies are largely driving the industry demand. Additionally, a higher intensity of research & development activities is noted in the countries of North America by institutions as well as manufacturers.
 

Mergers and acquisitions represent a higher competitive rivalry among industry participants

Prominent players operating in the market include 3D systems, Stratasys, Materialise NV and Renishaw among other players. Companies are noted to adopt organic and inorganic strategies to foster their market presence and as well as gain a competitive advantage in the market.
 

Some of the recent industry developments:

  • In January 2021, ZARE, an Italy-based 3D printing service bureau, acquired a majority stake in dental additive manufacturing specialist Proxera. The acquisition was targeted at ZARE’s entry in the industry. While ZARE is closely associated with Sandvik, a Sweden based multinational engineering company, the acquisition was also aimed at leveraging Proxera’s technology on a global level.
     
  • In August 2020, Siemens Healthineers acquired Varian Medical Technologies, Inc. in a deal valued at nearly US$ 16.4 billion. The acquisition was targeted at integrating the 3D printing assets of individual companies while strengthening the overall market presence of the company.
     

The healthcare 3D printing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product

  • Syringe based
  • Magnetic levitation
  • Laser based
  • Inkjet based

Market, By Technology

  • Fused deposition modelling (FDM)
  • Selective laser sintering (SLS)
  • Stereolithography
  • Others

Market, By Application

  • Biosensors
  • Medical
    • Pharmaceuticals
    • Prosthetics and implants
    • Tissue and organ generation
  • Dental

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
       

Frequently Asked Questions (FAQ) :

The market for healthcare 3D printing accounted for over USD 1.7 billion in 2020 and will grow at a CAGR of more than 22.3% through 2027.
The syringe segment accounted for over 40% market share in 2020 and will expand with the rising demand for 3D printers in embedded printing, food printing and bioprinting.
The industry value from the fused deposition modeling segment is forecast to be reach USD 3 billion by 2027 due to the demand for manufacturing implants used during surgeries.
The medical segment is expected to grow at a strong CAGR of around 22.5% through 2027 with increasing technological advancements in surgical implants and tissue scaffold printing.
North America healthcare 3D printing market size was valued at over USD 701.4 million in 2020 owing to the rising regulatory support to boost quality control measures.

Premium Report Details

  • Published Date: Jun 2021
  • Pages: 120
  • Tables: 231
  • Charts / Figures: 16
  • Companies covered: 21
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X